Pharmacology & Toxicology track

Entry in the world of pharmaceutical drugs with theoretical and practical knowledges

Active awareness of the different toxicology issues

Multidisciplinary approaches: neuroscience, cardiovascular, cancer, metabolism, etc.

General Basis for future careers in biomedical and pharmaceutical research

At the end of the course the students will be able to:

• Mobilise knowledge from a physiological point of view on the functioning of five major classes of drugs (anti-infection, anti-cancer, neurological, cardiovascular and hormonal)

• Acquire a current vision of the issues of pharmacogenetics, personalised medicine and pharmacovigilance.

• Critically analyse and present the practical steps of drug development, pharmaceutical industry and the drug-market policy.

• Interact with scientists and professionals from different backgrounds to learn and practice the various steps involved in the identification of a toxic substance, from the discovery of its mechanism of action to the press release and risk management.

Where

In the Department of Biomedical Sciences at Bugnon 27

Around 20 host laboratories propose affiliated projects

Ex-cathedra classes

Fundamental Principles

Pharmacokinetics-Pharmacodynamics
Pharmacogenetics-genomic (personalized medecine)

Practical Aspects

Drug design and discovery
Drug development
Optimization of drug treatment
Regulations and Regulatory agencies

System Pharmacology

Neuropharmacology
Cardiovascular pharmacology
Endocrine pharmacology

Principles of chemotherapy

Cancer
Infectious diseases

Toxicology

Pharmacotoxicology
Food toxicology
Ecotoxicology

E-learning activities

are part of the toxicology teaching and allow you to know more about pharmaco- as well as ecotoxico-vigilance

Seminar Series

on «Drug Discovery & Development» to meet with speakers performing research in industry

During the last years, we visited Roche, Merck Serono, Nestlé, Novartis, Debiopharm and Actelion to meet scientists performing research in industry and human research managers to talk about job opportunities for Master or PhD students in the respective company.

Problem-based learning activities will provide critical thinking about the Big Pharma with examples of drug development from the finding of an interesting active principle to a commercialized drug and its becoming when used by patients (pharmacovigilance).

2016 : Visit of Merck Production and R&D Site (Corsier-sur-Vevey)

31 mars 2017 : Visit of Celgene (Neuchâtel) 24 mars 2017 : Visit of Tridel (Lausanne)

Academic Research
Pharma
Biomedical Industries
Biotechs
Lab Med
Hospitals (FAMH)
Tox Labs
Patent Offices
Regulatory affairs
Governmental Agencies
Education